Suspension microarrays for the identification of the response patterns in hyperinflammatory diseases

Medical Engineering and Physics

Volumn 30, Issue 8, 2008, Pages 976-983

  Hsu, Hsin Yun ^a   SilkeWittemann, ^a   Schneider, E Marion ^b   Weiss, Manfred ^b   Joos, Thomas O ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Inflammatory diseases; Soluble receptors; Suspension microarray

Indexed keywords

INTENSIVE CARE UNITS; MULTIPLEXING; SUSPENSIONS (COMPONENTS);

ANALYTES; CHEMOKINES; CYTOKINES; HIGHER CONCENTRATIONS; INFLAMMATORY DISEASES; INTENSIVE CARE UNIT (ICU); INTER-ASSAY PRECISION; LUMINEX; MATRIX METALLOPROTEINASES; PLASMA CONCENTRATIONS; PLASMA PROTEINS; PLASMA SAMPLES; PROTEIN ARRAYS; RESPONSE PATTERNS; SANDWICH IMMUNOASSAYS; SELECTIN; SIMULTANEOUS ANALYSIS; SOLUBLE RECEPTOR; SOLUBLE RECEPTORS; SUSPENSION MICROARRAY;

PLASMAS;

ADVANCED GLYCATION END PRODUCT; BIOLOGICAL MARKER; CYTOKINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FAS ANTIGEN; FAS LIGAND; GLYCOPROTEIN GP 130; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MATRIX METALLOPROTEINASE; PLASMA PROTEIN; PROLYLLEUCYLGLYCINAMIDE; PROTEINASE; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; VASCULAR CELL ADHESION MOLECULE 1;

ACCURACY; AGED; ARTICLE; BLOOD SAMPLING; CROSS REACTION; ENZYME ACTIVITY; ENZYME IMMUNOASSAY; HUMAN; INFLAMMATION; INJURY; INTENSIVE CARE UNIT; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SEPSIS; SUSPENSION MICROARRAY;

BIOLOGICAL MARKERS; BLOOD CHEMICAL ANALYSIS; CYTOKINES; HUMANS; IMMUNOASSAY; INFLAMMATION; PROTEIN ARRAY ANALYSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 53049097300     PISSN: 13504533     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.medengphy.2008.01.003     Document Type: Article

References (51)

1. de Jager W., te Velthuis H., Prakken B.J., Kuis W., and Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin Diagn Lab Immunol 10 1 (2003) 133-139
2. Dasso J., Lee J., Bach H., and Mage R.G. A comparison of ELISA and flow microsphere-based assays for quantification of immunoglobulins. J Immunol Methods 263 1-2 (2002) 23-33
3. Prabhakar U., Eirikis E., and Davis H.M. Simultaneous quantification of proinflammatory cytokines in human plasma using the LabMAP assay. J Immunol Methods 260 1-2 (2002) 207-218
4. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., et al. Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110 3 (2004) 252-266
5. Templin M.F., Stoll D., Bachmann J., and Joos T.O. Protein microarrays and multiplexed sandwich immunoassays: what beats the beads?. Comb Chem High Throughput Screen 7 3 (2004) 223-229
6. Stoll D., Templin M.F., Bachmann J., and Joos T.O. Protein microarrays: applications and future challenges. Curr Opin Drug Discov Dev 8 2 (2005) 239-252
7. Bochicchio G.V., Napolitano L.M., Joshi M., Knorr K., Tracy J.K., Ilahi O., et al. Persistent systemic inflammatory response syndrome is predictive of nosocomial infection in trauma. J Trauma 53 2 (2002) 245-250 discussion 250-251
8. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101 6 (1992) 1644-1655
9. Matzinger P. The danger model: a renewed sense of self. Science 296 5566 (2002) 301-305
10. Martin G.S., Mannino D.M., Eaton S., and Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348 16 (2003) 1546-1554
11. Alberti C., Brun-Buisson C., Burchardi H., Martin C., Goodman S., Artigas A., et al. Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28 2 (2002) 108-121
12. Kayal S., Jais J.P., Aguini N., Chaudiere J., and Labrousse J. Elevated circulating E-selectin, intercellular adhesion molecule 1, and von Willebrand factor in patients with severe infection. Am J Respir Crit Care Med 157 3 Pt 1 (1998) 776-784
13. De Freitas I., Fernandez-Somoza M., Essenfeld-Sekler E., and Cardier J.E. Serum levels of the apoptosis-associated molecules, tumor necrosis factor-alpha/tumor necrosis factor type-I receptor and Fas/FasL, in sepsis. Chest 125 6 (2004) 2238-2246
14. Marshall J.C. Clinical trials of mediator-directed therapy in sepsis: what have we learned?. Intensive Care Med 26 Suppl 1 (2000) S75-S83
15. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (I). Crit Care Med 32 3 (2004) 858-873
16. Dellinger R.P., Carlet J.M., Masur H., Gerlach H., Calandra T., Cohen J., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock (II). Intensive Care Med 30 4 (2004) 536-555
17. Heuer J.G., Zhang T., Zhao J., Ding C., Cramer M., Justen K.L., et al. Adoptive transfer of in vitro-stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis. J Immunol 174 11 (2005) 7141-7146
18. Heuer J.G., Sharma G.R., Gerlitz B., Zhang T., Bailey D.L., Ding C., et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit Care Med 32 7 (2004) 1570-1578
19. Perper S.J., Browning B., Burkly L.C., Weng S., Gao C., Giza K., et al. TWEAK is a novel arthritogenic mediator. J Immunol 177 4 (2006) 2610-2620
20. Calvano S.E., van der Poll T., Coyle S.M., Barie P.S., Moldawer L.L., and Lowry S.F. Monocyte tumor necrosis factor receptor levels as a predictor of risk in human sepsis. Arch Surg 131 4 (1996) 434-437
21. Pruitt J.H., Welborn M.B., Edwards P.D., Harward T.R., Seeger J.W., Martin T.D., et al. Increased soluble interleukin-1 type II receptor concentrations in postoperative patients and in patients with sepsis syndrome. Blood 87 8 (1996) 3282-3288
22. Keh D., Boehnke T., Weber-Cartens S., Schulz C., Ahlers O., Bercker S., et al. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study. Am J Respir Crit Care Med 167 4 (2003) 512-520
23. Leone M., Boutiere B., Camoin-Jau L., Albanese J., Horschowsky N., Mege J.L., et al. Systemic endothelial activation is greater in septic than in traumatic-hemorrhagic shock but does not correlate with endothelial activation in skin biopsies. Crit Care Med 30 4 (2002) 808-814
24. Heuer J.G., Cummins D.J., and Edmonds B.T. Multiplex proteomic approaches to sepsis research: case studies employing new technologies. Expert Rev Proteomics 2 5 (2005) 669-680
25. Saeed A.I., Sharov V., White J., Li J., Liang W., Bhagabati N., et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34 2 (2003) 374-378
26. Findlay J.W., Smith W.C., Lee J.W., Nordblom G.D., Das I., DeSilva B.S., et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J Pharm Biomed Anal 21 6 (2000) 1249-1273
27. Sanchez-Carbayo M. Antibody arrays: technical considerations and clinical applications in cancer. Clin Chem 52 9 (2006) 1651-1659
28. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 5 4 (2006) 310-320
29. Oberholzer A., Oberholzer C., and Moldawer L.L. Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16 2 (2001) 83-96
30. Kriebel F., Wittemann S., Hsu H.Y., Joos T., Weiss M., and Schneider E.M. Caspase-3 activation, Bcl-2 contents, and soluble FAS-ligand are not related to the inflammatory marker profile in patients with sepsis and septic shock. Ann NY Acad Sci 1090 (2006) 168-176
31. Pinsky M.R., Vincent J.L., Deviere J., Alegre M., Kahn R.J., and Dupont E. Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103 2 (1993) 565-575
32. Riedemann N.C., Guo R.F., and Ward P.A. Novel strategies for the treatment of sepsis. Nat Med 9 5 (2003) 517-524
33. Cinat M., Waxman K., Vaziri N.D., Daughters K., Yousefi S., Scannell G., et al. Soluble cytokine receptors and receptor antagonists are sequentially released after trauma. J Trauma 39 1 (1995) 112-118 discussion 118-120
34. Askenasy N., Yolcu E.S., Yaniv I., and Shirwan H. Induction of tolerance using Fas ligand: a double-edged immunomodulator. Blood 105 4 (2005) 1396-1404
35. Hotchkiss R.S., Schmieg Jr. R.E., Swanson P.E., Freeman B.D., Tinsley K.W., Cobb J.P., et al. Rapid onset of intestinal epithelial and lymphocyte apoptotic cell death in patients with trauma and shock. Crit Care Med 28 9 (2000) 3207-3217
36. Hogg N. Roll, roll, roll your leucocyte gently down the vein. Immunol Today 13 4 (1992) 113-115
37. Strieter R.M., and Kunkel S.L. Acute lung injury: the role of cytokines in the elicitation of neutrophils. J Investig Med 42 4 (1994) 640-651
38. Korthuis R.J., Anderson D.C., and Granger D.N. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care 9 1 (1994) 47-71
39. Sessler C.N., Windsor A.C., Schwartz M., Watson L., Fisher B.J., Sugerman H.J., et al. Circulating ICAM-1 is increased in septic shock. Am J Respir Crit Care Med 151 5 (1995) 1420-1427
40. Xu H., Gonzalo J.A., St Pierre Y., Williams I.R., Kupper T.S., Cotran R.S., et al. Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med 180 1 (1994) 95-109
41. Rogy M.A., Oldenburg H.S., Coyle S., Trousdale R., Moldawer L.L., and Lowry S.F. Correlation between Acute Physiology and Chronic Health Evaluation (APACHE) III score and immunological parameters in critically ill patients with sepsis. Br J Surg 83 3 (1996) 396-400
42. Suda T., Okazaki T., Naito Y., Yokota T., Arai N., Ozaki S., et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 154 8 (1995) 3806-3813
43. Lynch D.H., Ramsdell F., and Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses. Immunol Today 16 12 (1995) 569-574
44. Bone R.C. Sir Isaac Newton, sepsis, SIRS, and CARS. Crit Care Med 24 7 (1996) 1125-1128
45. Fischer E., Van Zee K.J., Marano M.A., Rock C.S., Kenney J.S., Poutsiaka D.D., et al. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79 9 (1992) 2196-2200
46. Power C., Fanning N., and Redmond H.P. Cellular apoptosis and organ injury in sepsis: a review. Shock 18 3 (2002) 197-211
47. Hotchkiss R.S., and Nicholson D.W. Apoptosis and caspases regulate death and inflammation in sepsis. Nat Rev Immunol 6 11 (2006) 813-822
48. Carrigan S.D., Scott G., and Tabrizian M. Toward resolving the challenges of sepsis diagnosis. Clin Chem 50 8 (2004) 1301-1314
49. Liu M.Y., Xydakis A.M., Hoogeveen R.C., Jones P.H., Smith E.O., Nelson K.W., et al. Multiplexed analysis of biomarkers related to obesity and the metabolic syndrome in human plasma, using the Luminex-100 system. Clin Chem 51 7 (2005) 1102-1109
50. Caiazzo Jr. R.J., Tassinari O.W., Ehrlich J.R., and Liu B.C. Autoantibody microarrays for biomarker discovery. Expert Rev Proteomics 4 2 (2007) 261-272
51. Lu J., Getz G., Miska E.A., Alvarez-Saavedra E., Lamb J., Peck D., et al. MicroRNA expression profiles classify human cancers. Nature 435 7043 (2005) 834-838